# Adderall XR

NDC: 54092-381
Generic name: Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20020522

FDA application: NDA021303

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 1.25 mg/1
- AMPHETAMINE SULFATE: 1.25 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 1.25 mg/1
- DEXTROAMPHETAMINE SULFATE: 1.25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54092-381"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54092-381
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aff45863-ffe1-4d4f-8acf-c7081512a6c0